Education
About Us
Working with TipRanks
Follow Us
Beauty Health (SKIN)
NASDAQ:SKIN
SKIN Stock Chart & Stats
$1.29
-$0.07(-3.95%)
At close: 4:00 PM EST
$1.29
-$0.07(-3.95%)
Day’s Range― - ―
52-Week Range$0.78 - $2.69
Previous CloseN/A
Volume138.49K
Average Volume (3M)1.04M
Market Cap
$175.02M
Enterprise Value$432.69M
Total Cash (Recent Filing)$212.00M
Total Debt (Recent Filing)$376.73M
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Mar 18, 2026EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding126,825,390
10 Day Avg. Volume926,645
30 Day Avg. Volume1,036,656
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)3.80
Price to Sales (P/S)0.59
P/FCF Ratio21.08
Enterprise Value/Market Cap2.47
Enterprise Value/Revenue1.40
Enterprise Value/Gross Profit2.27
Enterprise Value/Ebitda20.90
Forecast
1Y Price Target
$2.13Price Target Upside65.12% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Leadership And ManagementA clearer path of profitability and margin expansion is anticipated under new leadership.
Product Mix And ProfitabilityThe company's consumables now represent 71% of net sales and carry stronger margins compared to delivery systems, supporting an EBITDA margin outperformance.
Revenue And Financial GuidanceManagement lifted the lower end of the 2025 revenue guidance range and increased Adjusted EBITDA expectations for the year.
Bears Say
Interest Rates And Market ConditionsNew machine placements are likely to remain pressured due to the higher interest rate environment and uncertain macro conditions, which could limit consumables sales.
Macroeconomic ChallengesThere are continued declines in device sales driven by a worsening macroeconomic and credit environment.
Strategic UncertaintyThere will be some uncertainty around the near-term strategy for SKIN as Ms. Beck was more consumer-oriented based on her background and strategy while Mr. Malha is more experienced around the competitive medical device industry.
Beauty Health News
SKIN FAQ
What was Beauty Health’s price range in the past 12 months?
Beauty Health lowest stock price was $0.78 and its highest was $2.69 in the past 12 months.
What is Beauty Health’s market cap?
Beauty Health’s market cap is $175.02M.
When is Beauty Health’s upcoming earnings report date?
Beauty Health’s upcoming earnings report date is Mar 18, 2026 which is in 130 days.
How were Beauty Health’s earnings last quarter?
Beauty Health released its earnings results on Nov 06, 2025. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.074 by -$0.016.
Is Beauty Health overvalued?
According to Wall Street analysts Beauty Health’s price is currently Undervalued.
Does Beauty Health pay dividends?
Beauty Health does not currently pay dividends.
What is Beauty Health’s EPS estimate?
Beauty Health’s EPS estimate is -0.04.
How many shares outstanding does Beauty Health have?
Beauty Health has 126,825,390 shares outstanding.
What happened to Beauty Health’s price movement after its last earnings report?
Beauty Health reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.074. Following the earnings report the stock price went up 8.527%.
Which hedge fund is a major shareholder of Beauty Health?
Currently, no hedge funds are holding shares in SKIN
Beauty Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.13 (65.12% Upside)
$2.13 (65.12% Upside)
Hedge Fund Trend
Increased
By 1.6M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.85%
12-Months-Change
Fundamentals
Return on Equity
-26.54%
Trailing 12-Months
Asset Growth
-28.70%
Trailing 12-Months
Company Description
Beauty Health
Beauty Health (SKIN) is a leading innovator in the beauty and wellness industry, focusing on skincare products that harness the power of health and beauty science. The company specializes in developing and marketing advanced skin health solutions, including proprietary formulations that combine dermatological expertise with consumer-friendly applications. Its core products are designed to enhance skin appearance and health, catering to a diverse clientele that values both efficacy and sustainability in beauty care.
SKIN Company Deck
SKIN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative elements. On the positive side, there was growth in adjusted EBITDA, an improved consumable mix, successful new product launches, and significant inventory management achievements. However, these were countered by declines in overall revenue, significant drops in the device segment and APAC revenues, and concerns about the churn rate among providers. While operational improvements and strategic initiatives offer promise, the ongoing pressures in device sales and regional performance present notable challenges.View all SKIN earnings summariesSKIN Stock 12 Month Forecast
Average Price Target
$2.13
▲(65.12% Upside)
Technical Analysis
Ownership Overview
14.57% Insiders
16.66% Mutual Funds
0.04% Other Institutional Investors
60.65% Public Companies and
Individual Investors